GYPE and Parkinson disease: In recent years, GPe has garnered considerable attention as a potential therapeutic target for various clinical conditions, including Parkinson's disease (PD) [6], Huntington's disease [7], epilepsy [8], etc. In PD, the over‐inhibition of the GPe by GABAergic neurons from the caudate putamen (CPu) is considered a key factor in the manifestation of motor symptoms [9].